The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment and outcome(s) of a large cohort of Italian patients (pts) with poor-risk metastatic renal cell carcinoma (prRCC).
Alessandra Felici
No relevant relationships to disclose
Daniele Santini
No relevant relationships to disclose
Ugo De Giorgi
No relevant relationships to disclose
Michele De Tursi
No relevant relationships to disclose
Gaetano Facchini
No relevant relationships to disclose
Matteo Santoni
No relevant relationships to disclose
Elena Verzoni
No relevant relationships to disclose
Lisa Derosa
No relevant relationships to disclose
Giuseppe di Lorenzo
No relevant relationships to disclose
Giuseppe Badalamenti
No relevant relationships to disclose
Paolo Marchetti
No relevant relationships to disclose
Enrico Cortesi
No relevant relationships to disclose
Marco Maruzzo
No relevant relationships to disclose
Francesco Massari
No relevant relationships to disclose
Flavia Longo
No relevant relationships to disclose
Laura Noto
No relevant relationships to disclose
Joan Carles
No relevant relationships to disclose
Francesco Maria Guida
No relevant relationships to disclose
Isabella Sperduti
No relevant relationships to disclose
Michele Milella
No relevant relationships to disclose